Literature DB >> 9026404

Update on the diagnosis and management of osteomyelitis.

J T Mader1, M Ortiz, J H Calhoun.   

Abstract

Osteomyelitis can be classified by duration, pathogenesis, location, extent, and host status. Bone infections are currently classified by the Waldvogel or the Cierny-Mader classification. Because the Waldvogel classification is an etiologic system and the Cierny-Mader classification is descriptive, both classifications can be simultaneously used. The Cierny-Mader classification is based on the anatomy of the bone infection and the physiology of the host. Cierny-Mader staging allows stratification of long bone osteomyelitis and the development of comprehensive treatment guidelines for each stage. Current trends in long bone osteomyelitis therapy emphasize early diagnosis and aggressive treatment. Radiographs and bone cultures are the mainstays of diagnosis. Imaging with radionuclide scans, computerized tomography, and magnetic resonance imaging are used when the diagnosis of osteomyelitis is equivocal or to help guage the extent bone and soft tissue infection. Surgical treatment involves débridement of necrotic bone and tissue, obtaining appropriate cultures, managing dead space, and, when necessary, obtaining bone stability. Medical therapy includes improving any host deficiencies, initial antibiotic selection, and antibiotic modification based on culture results. Antibiotic delivery has expanded to include effective oral agents and local therapy with antibiotics mixed in polymethylmethacrylate. Cierny-Mader staging was developed to describe long bone osteomyelitis. This staging system has to be modified to describe diabetic foot osteomyelitis and vertebral osteomyelitis. Osteomyelitis in patients with diabetes mellitus involves the bones of the feet or ankles. The vascular and neurologic status of the patient must be carefully accessed. Patients may be managed with local débridement surgery or ablative surgery plus 2 to 4 weeks of antibiotic therapy depending on whether all of the osteomyelitis is surgically removed. If the patient does not wish surgery or is not a surgical candidate, suppressive antibiotic therapy can be used. Vertebral osteomyelitis is usually hematogenous in origin. The diagnosis is made by bone cultures, histology, and radiographs. Magnetic resonance imaging and technetium scans are useful in making the diagnosis and in gauging the extent of the bone and soft tissue infection. Therapy requires parenteral antibiotic therapy and may include early surgery and stabilization. The choice of an antibiotic therapy is guided by the bone biopsy or débridement culture results.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9026404

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  16 in total

Review 1.  Selective drug delivery to bone using acidic oligopeptides.

Authors:  Junko Ishizaki; Yoshihiro Waki; Tatsuo Takahashi-Nishioka; Koichi Yokogawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

2.  Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009.

Authors:  Hilal Maradit Kremers; Macaulay E Nwojo; Jeanine E Ransom; Christina M Wood-Wentz; L Joseph Melton; Paul M Huddleston
Journal:  J Bone Joint Surg Am       Date:  2015-05-20       Impact factor: 5.284

Review 3.  Bone and joint infections in the elderly: practical treatment guidelines.

Authors:  J T Mader; M E Shirtliff; S Bergquist; J H Calhoun
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

4.  Progressive massive osteolysis secondary to benign squamous epithelial colonisation in chronic osteomyelitis.

Authors:  Radhesh K Lalam; Victor N Cassar-Pullicino; D Chas Mangham; Chas Mangham; Glen Clewer; Paul Cool
Journal:  Skeletal Radiol       Date:  2006-03-25       Impact factor: 2.199

5.  Bone cultures from war-wounded civilians in the Middle East: a surgical prospective.

Authors:  Patrick Hérard; François Boillot; Rasheed M Fakhri
Journal:  Int Orthop       Date:  2017-01-18       Impact factor: 3.075

6.  Osteomyelitis of the long bones.

Authors:  Jason H Calhoun; M M Manring; Mark Shirtliff
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

7.  Aspergillus osteomyelitis of the proximal humerus: a case report.

Authors:  Gregory L Hall; Esperanza Villanueva-Siles; Ross M Borzykowski; Konrad I Gruson; Howard D Dorfman; David S Geller
Journal:  Skeletal Radiol       Date:  2012-03-31       Impact factor: 2.199

Review 8.  Diagnosis and management of osteomyelitis. Decision analytic and pharmacoeconomic considerations.

Authors:  M Tavakoli; P Davey; B A Clift; H T Davies
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

9.  Bone-targeting of quinolones conjugated with an acidic oligopeptide.

Authors:  Tatsuo Takahashi; Koichi Yokogawa; Naoki Sakura; Masaaki Nomura; Shinjiro Kobayashi; Ken-ichi Miyamoto
Journal:  Pharm Res       Date:  2008-07-29       Impact factor: 4.200

10.  Comparison of the selection of antimicrobial resistance in fecal Escherichia coli during enrofloxacin administration with a local drug delivery system or with intramuscular injections in a swine model.

Authors:  Romain Béraud; Louis Huneault; Dave Bernier; Francis Beaudry; Ann Letellier; Jérôme R E del Castillo
Journal:  Can J Vet Res       Date:  2008-07       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.